Market Insights: Eli Lilly's Rating and Boeing's Downgrade Concerns

This chapter explores recent stock market developments, spotlighting Eli Lilly's buy rating amid revenue concerns and Boeing's potential downgrade by Moody's. It also examines broader market trends leading up to a crucial Federal Reserve rate decision, including discussions on possible rate cuts and their economic implications.